Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech IncfiledCriticalGenentech Inc
Publication of AR098781A1publicationCriticalpatent/AR098781A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente se refiere a ligadores peptidomiméticos y sus conjugados de anticuerpo-fármaco, a composiciones farmacéuticas que los contienen y a su uso en terapia para la prevención o el tratamiento de cáncer.This refers to peptidomimetic linkers and their antibody-drug conjugates, pharmaceutical compositions containing them and their use in therapy for the prevention or treatment of cancer.
ARP140104699A2013-12-162014-12-17
PEPTIDOMIMETIC COMPOUNDS AND ANTIBODY-DRUG CONJUGATES OF THE SAME
AR098781A1
(en)
Thienopyrimidine derivative compounds; Preparation process; pharmaceutical composition that includes them; pharmaceutical combination; use in the treatment of cancers and autoimmune diseases.
Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
Compounds derived from 5-fluoro-2'-deoxyuridine phosphoramidate; preparation procedure; pharmaceutical composition that includes them; its use in the treatment or prophylaxis of cancer.